Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study

European Journal of Heart Failure
Gad CotterBeth A Davison

Abstract

Growth differentiation factor 15 (GDF-15) was found to be upregulated in patients with chronic heart failure (HF) and associated with disease severity, however, data on patients with acute heart failure (AHF) is lacking. Levels of GDF-15 were measured at pre-specified time-points (baseline and at days 2, 5, 14, and 60) in patients enrolled in the placebo-controlled RELAXin in Acute Heart Failure (RELAX-AHF) study, which examined the effect of serelaxin in 1161 patients with AHF, systolic blood pressure >125 mmHg, and mild to moderate renal impairment. Neither baseline nor changes in GDF-15 were associated with the degree of dyspnoea or dyspnoea relief. After adjustment for baseline characteristics, baseline GDF-15 was not associated with the composite endpoint of heart failure or renal failure (HF/RF) readmission at 60 days/cardiovascular (CV) death or CV death at 180 days. In contrast, larger increases in GDF-15 levels at days 2 and 14 were associated with a greater risk of 60-day HF/RF rehospitalizations/CV death and CV death at 180 days. Serelaxin treatment was associated with significantly larger decreases of GDF-15 at days 2 and 5 than placebo. In AHF patients enrolled in the RELAX-AHF study, increases in GDF-15 levels, bu...Continue Reading

References

Apr 4, 2002·Psychological Methods·David P MacKinnonVirgil Sheets
Jul 19, 2005·Nature Medicine·Monika BuitragoStefan Engelhardt
Sep 13, 2005·The Journal of Surgical Research·Teresa A ZimmersLeonidas G Koniaris
Sep 11, 2007·Journal of the American College of Cardiology·Tibor KempfKai C Wollert
Sep 24, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Fangfang WangWei Gao
Nov 13, 2012·Lancet·John R TeerlinkUNKNOWN RELAXin in Acute Heart Failure (RELAX-AHF) Investigators

❮ Previous
Next ❯

Citations

Mar 1, 2016·Expert Review of Cardiovascular Therapy·Roberto LatiniLidia Staszewsky
Jun 20, 2016·Atherosclerosis·Ilze Bot, Johan Kuiper
Nov 14, 2016·International Journal of Cardiology·Marco MetraAndrew J Stewart Coats
Mar 24, 2017·Heart Failure Reviews·Frank KramerMihai Gheorghiade
May 26, 2017·European Journal of Heart Failure·Domingo A Pascual-Figal
Jan 31, 2017·European Journal of Heart Failure·Biniyam G DemisseiAdriaan A Voors
Mar 8, 2018·Heart Failure Reviews·Michele CorrealeUNKNOWN Master Program Students on Drug Development for Heart Failure
Jul 26, 2018·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Moritz MirnaAlexander Lauten
Oct 18, 2018·European Journal of Heart Failure·Kai C Wollert
Dec 12, 2017·Current Opinion in Cardiology·Kegan J MoneghettiFrancois Haddad
Nov 30, 2018·Transfusion·Robert B KlandermanAlexander P J Vlaar
Feb 2, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Ferran RuedaAntoni Bayés-Genís
Jan 10, 2020·Current Heart Failure Reports·Thanat Chaikijurajai, W H Wilson Tang
Jan 8, 2017·Clinical Chemistry·Nasrien E Ibrahim, James L Januzzi
Jan 8, 2017·Clinical Chemistry·Kai C WollertLars Wallentin
Oct 31, 2019·Critical Reviews in Clinical Laboratory Sciences·Maria ArkoumaniIoannis Papassotiriou
Sep 29, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Eric RullmanThomas Gustafsson
Apr 21, 2020·Endocrine Reviews·Samuel M LockhartStephen O'Rahilly
Jul 3, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Bernadet T SantemaAdriaan A Voors
Jun 30, 2018·International Journal of Molecular Medicine·Min LiQiyi Zeng
Aug 23, 2019·Scientific Reports·Darae KimEun-Seok Jeon
May 20, 2020·ESC Heart Failure·Marian WesselingSaskia C A de Jager
Aug 27, 2019·The International Journal of Neuroscience·Xiaoyu Dong, Jianfei Nao
Sep 28, 2017·Heart Failure Reviews·Hani N Sabbah
Jul 29, 2017·European Heart Journal Supplements : Journal of the European Society of Cardiology·Nadia AspromonteMarco Migliardi
Oct 26, 2018·Circulation Research·Nasrien E Ibrahim, James L Januzzi
Aug 30, 2019·European Journal of Clinical Investigation·Henrike ArfstenNoemi Pavo
Feb 11, 2021·Arquivos brasileiros de cardiologia·Bruna Miers MayLuis Eduardo Rohde
Mar 13, 2018·Trends in Endocrinology and Metabolism : TEM·Teja Devarakonda, Fadi N Salloum
Apr 15, 2021·Heart Failure Reviews·Vincenzo CastiglioneMichele Emdin
Apr 24, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Rosaria Vincenza GiglioManfredi Rizzo
May 4, 2021·ESC Heart Failure·Patrícia LourençoPaulo Bettencourt
Jan 22, 2020·Cardiorenal Medicine·Chongyu ZhangChen Liu
May 23, 2019·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Erdoğan SökmenBilal İlanbey
Jul 23, 2019·Heart, Lung & Circulation·Moritz MirnaMarcus Franz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.